S31 Olga Obrezanova

Lonza Biologics plc
Applied Protein Services
The Portway
Granta Park
Cambridge CB21 6GS, UK

Papers:
S31 Developability and pre-process risk assessment in biopharmaceutical development: a critical aspect in QbD implementation